Jeonjinbio Co. Ltd Total Liabilities

Latest as of September 2025: ₩1.27 Billion KRW ≈ $862.54K USD

Jeonjinbio Co. Ltd total liabilities. Based on the latest financial reports, Jeonjinbio Co. Ltd (110020) has total liabilities worth ₩1.27 Billion KRW (≈ $862.54K USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 110020 asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Jeonjinbio Co. Ltd (2015–2024)

Total liabilities of Jeonjinbio Co. Ltd from 2015 to 2024. This chart illustrates how Jeonjinbio Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore how much of Jeonjinbio Co. Ltd's assets are long-term investments to see how much of total assets are deployed in long-term investments.

Jeonjinbio Co. Ltd Competitors by Total Liabilities

The table below lists competitors of Jeonjinbio Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Berkah Beton Sadaya Tbk PT JK:BEBS	Indonesia	Rp88.66 Billion
bioAffinity Technologies, Inc. NASDAQ:BIAF	USA	$3.68 Million
Greater Than AB ST:GREAT	Sweden	Skr47.90 Million
TRANSTEMA GROUP AB O.N. F:9G8	Germany	€970.33 Million
Elicera Therapeutics AB ST:ELIC	Sweden	Skr6.97 Million
Beamtree Holdings Ltd AU:BMT	Australia	AU$13.76 Million
Youlife Group Inc. American Depositary Shares NASDAQ:YOUL	USA	$489.61 Million
Ozaurum Resources Ltd AU:OZM	Australia	AU$493.01K

Liability Composition Analysis (2015–2024)

This chart breaks down Jeonjinbio Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Jeonjinbio Co. Ltd balance sheet assets.

Liquidity & Leverage Metrics

Jeonjinbio Co. Ltd Total Liabilities Ratios Explained

Jeonjinbio Co. Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	8.77	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.07	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.07	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Jeonjinbio Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Jeonjinbio Co. Ltd (2015–2024)

The table below shows the annual total liabilities of Jeonjinbio Co. Ltd from 2015 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩1.19 Billion ≈ $807.71K	-89.62%
2023-12-31	₩11.48 Billion ≈ $7.78 Million	+37.39%
2022-12-31	₩8.36 Billion ≈ $5.66 Million	-40.38%
2021-12-31	₩14.02 Billion ≈ $9.50 Million	+89.15%
2020-12-31	₩7.41 Billion ≈ $5.02 Million	+111.04%
2019-12-31	₩3.51 Billion ≈ $2.38 Million	+9.45%
2018-12-31	₩3.21 Billion ≈ $2.17 Million	-16.15%
2017-12-31	₩3.83 Billion ≈ $2.59 Million	+7.86%
2016-12-31	₩3.55 Billion ≈ $2.40 Million	-55.35%
2015-12-31	₩7.95 Billion ≈ $5.39 Million	--

About Jeonjinbio Co. Ltd

KQ:110020 Korea Specialty Chemicals

Market Cap

$13.17 Million

₩19.43 Billion KRW

Market Cap Rank

#26206 Global

#1964 in Korea

Share Price

₩2145.00

Change (1 day)

-1.61%

52-Week Range

₩1641.00 - ₩3025.00

All Time High

₩16700.00